Co-occurrence of bipolar disorder and personality disorders in the United States: Prevalence, suicidality, and the impact of substance abuse.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
15 01 2024
Historique:
received: 15 06 2023
revised: 07 10 2023
accepted: 13 10 2023
medline: 23 11 2023
pubmed: 18 10 2023
entrez: 17 10 2023
Statut: ppublish

Résumé

This study investigates prevalence rates of specific personality disorders (PDs) in individuals with bipolar disorder (BD) and their impact on substance abuse and suicidality, addressing existing gaps in the literature. Using Nationwide Inpatient Sample data (2016-2020), adult hospitalizations for BD with coexisting PDs were analyzed. Study variables were defined using ICD-10-CM codes. Prevalence of PD were reported as cases per 100,000 BD admissions. Regression models assessed the association between substance abuse and suicidality. About 993,000 admissions for BD were analyzed. The cohort was predominantly Caucasian (70.5 %) with higher female representation (54.5 %). The mean age was 41 years. 89.4 % of individuals had a Charlson Comorbidity Index score ≤ 1. The most common diagnostic subtype was manic episode of BD with or without psychotic features (32.3 %). Coexisting PDs were observed in 12.2 % of the population, with borderline PD (8.2 %) and antisocial PD (2.6 %) being most prevalent. Substance abuse was common (44.8 %), with cannabis (23.8 %), alcohol (19.4 %), cocaine (10.5 %), and opioids (9.6 %) being most reported. Substance abuse was higher in individuals with BD and PD (50 %) compared to BD alone (44.1 %). 596 suicide attempts were recorded (60 per 100,000 BD admissions). Substance abuse and coexisting PD in bipolar individuals elevated the likelihood of attempts (P < 0.001). Use of administrative data (retrospective, inpatient); treatment not studied. The study reveals a notable prevalence of PDs in individuals with BD, with increased likelihood of substance abuse and suicide attempts in those with coexisting BD and PD compared to BD alone.

Sections du résumé

BACKGROUND
This study investigates prevalence rates of specific personality disorders (PDs) in individuals with bipolar disorder (BD) and their impact on substance abuse and suicidality, addressing existing gaps in the literature.
METHODS
Using Nationwide Inpatient Sample data (2016-2020), adult hospitalizations for BD with coexisting PDs were analyzed. Study variables were defined using ICD-10-CM codes. Prevalence of PD were reported as cases per 100,000 BD admissions. Regression models assessed the association between substance abuse and suicidality.
RESULTS
About 993,000 admissions for BD were analyzed. The cohort was predominantly Caucasian (70.5 %) with higher female representation (54.5 %). The mean age was 41 years. 89.4 % of individuals had a Charlson Comorbidity Index score ≤ 1. The most common diagnostic subtype was manic episode of BD with or without psychotic features (32.3 %). Coexisting PDs were observed in 12.2 % of the population, with borderline PD (8.2 %) and antisocial PD (2.6 %) being most prevalent. Substance abuse was common (44.8 %), with cannabis (23.8 %), alcohol (19.4 %), cocaine (10.5 %), and opioids (9.6 %) being most reported. Substance abuse was higher in individuals with BD and PD (50 %) compared to BD alone (44.1 %). 596 suicide attempts were recorded (60 per 100,000 BD admissions). Substance abuse and coexisting PD in bipolar individuals elevated the likelihood of attempts (P < 0.001).
LIMITATIONS
Use of administrative data (retrospective, inpatient); treatment not studied.
CONCLUSION
The study reveals a notable prevalence of PDs in individuals with BD, with increased likelihood of substance abuse and suicide attempts in those with coexisting BD and PD compared to BD alone.

Identifiants

pubmed: 37848089
pii: S0165-0327(23)01276-4
doi: 10.1016/j.jad.2023.10.087
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-7

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no relevant financial or non-financial interests to disclose.

Auteurs

Kenechukwu Anona (K)

Greater Manchester Mental Health National Health Service Foundation Trust, UK.

Oluwatobi Olaomi (O)

University of Ibadan, College of Medicine, Oyo State, Nigeria.

Ebehireme Udegbe (E)

Ambrose Alli University, Ekpoma, Edo State, Nigeria.

Fidelis Uwumiro (F)

Jos University Teaching Hospital, Jos, Plateau State, Nigeria. Electronic address: frankdumelo@gmail.com.

Ebere-Bank Tuaka (EB)

Rivers State University Teaching Hospital, Port Harcourt, Nigeria.

Nnenna Okafor (N)

All Saints University College of Medicine, Belair Kingstown, Saint Vincent and the Grenadines.

Adebimpe Adeyinka (A)

Obafemi Awolowo University, Ile-Ife, Osun state, Nigeria.

Chinwendu Obijuru (C)

College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu State, Nigeria.

Victory Okpujie (V)

College of Medicine, University of Benin, Benin City, Edo State, Nigeria.

Micheal Bojerenu (M)

St. Barnabas Hospital SBH Health System, Bronx, NY, USA.

Mojeed Opeyemi (M)

Federal Medical Center Abeokuta, Ogun state, Nigeria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH